Search

AtriCure Inc

Gesloten

SectorGezondheidszorg

58.13 -1.21

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

57.67

Max

59.79

Belangrijke statistieken

By Trading Economics

Inkomsten

8.8M

9M

Verkoop

12M

154M

K/W

Sectorgemiddelde

265.667

56.432

EPS

0.18

Winstmarge

5.83

Werknemers

1,350

EBITDA

-3.8M

3.2M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

-5.34% downside

Dividenden

By Acuity

Volgende Winsten

28 okt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

1.1B

2.8B

Vorige openingsprijs

59.34

Vorige sluitingsprijs

58.13

Nieuwssentiment

By Acuity

34%

66%

56 / 339 Rangschikking in Healthcare

AtriCure Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

18 sep 2026, 20:02 UTC

AtriCure Inc shares fell sharply, breaking a recent pattern of higher daily closes amid unusually high market volume.

17 sep 2026, 20:07 UTC

AtriCure Inc is advancing in today's trading session, continuing a trend that has seen the stock rise significantly since Wednesday's close.

16 sep 2026, 19:44 UTC

AtriCure Inc is trading higher, maintaining a price above its 20-day moving average and marking gains in four consecutive sessions.

15 sep 2026, 20:07 UTC

News

AtriCure Inc's stock is higher following an insider sale of 5,313 shares by Board Member Regina E. Groves for about $288,070.

14 sep 2026, 20:07 UTC

News

AtriCure reports gross revenue of $534.53 million and a net income loss of $11.45 million, with shares advancing amid positive market sentiment.

11 sep 2026, 22:11 UTC

AtriCure Inc. shares are lower in after-market trading, continuing a decline since Friday's close amid notably weak overall market conditions.

9 sep 2026, 20:07 UTC

AtriCure Inc. shares are lower today, following a notable drop at the open amid broader market volatility. No specific news was identified for the decline.

8 sep 2026, 20:01 UTC

News

AtriCure Inc. is trading higher as analysts issue mixed ratings and price targets, with BTIG raising its target to $55.00.

3 sep 2026, 20:01 UTC

AtriCure Inc shares are lower during Thursday's session, continuing a decline since Wednesday. No specific news was identified to explain the movement.

2 sep 2026, 20:01 UTC

News

AtriCure Inc shares are higher following an upgrade from Needham, raising the price target to $64.00 from $45.00 while maintaining a Buy rating.

1 sep 2026, 20:08 UTC

AtriCure Inc. shares are higher today, driven by gains in the Health Care Equipment sub-sector. The stock remains strong above its 20-day moving average.

31 aug 2026, 19:26 UTC

AtriCure Inc's shares are lower amid broader market sentiment influenced by interest rate concerns, despite remaining above their 20-day moving average.

28 aug 2026, 19:16 UTC

AtriCure Inc shares are lower today, following an early dip. Broader market concerns about inflation and growth expectations may be influencing sentiment.

26 aug 2026, 19:08 UTC

News

AtriCure Inc shares are lower amid Health Care Equipment sector weakness and an insider sale of 9,370 shares valued at $458,099.

24 aug 2026, 19:36 UTC

News

AtriCure's price target raised to $55 from $45 by BTIG. Shares are higher, reflecting positive sentiment on the company's growth prospects.

20 aug 2026, 19:46 UTC

AtriCure Inc shares are higher today, maintaining gains since Wednesday's close, despite earlier fluctuations. The stock remains above its 20-day moving average.

19 aug 2026, 20:01 UTC

AtriCure Inc shares are trading higher during Wednesday's session, continuing a strong upward trajectory since Tuesday's close, despite no specific news identified.

18 aug 2026, 19:16 UTC

AtriCure Inc shares are higher today, continuing momentum from Monday's close. Broader market factors include rising U.S. Treasury yields amid inflation concerns.

17 aug 2026, 22:46 UTC

AtriCure Inc is trading higher in after-market hours, with no specific news identified for the move. The stock remains above its 20-day moving average.

12 aug 2026, 20:06 UTC

AtriCure Inc shares are higher today, continuing a nine-session streak of gains. The stock remains above its 20-day moving average.

11 aug 2026, 22:41 UTC

AtriCure Inc shares are higher in after-market trading, continuing a recent trend of strength amid changing monetary policies from central banks.

7 aug 2026, 20:03 UTC

AtriCure Inc's shares are higher during Friday's session, continuing an upward trend since Thursday's close, and remain above their 20-day moving average.

6 aug 2026, 19:12 UTC

AtriCure Inc shares are higher, benefiting from an upward trend in the Health Care Equipment sub-sector. Earlier, the stock peaked before a slight pullback.

5 aug 2026, 19:51 UTC

AtriCure Inc shares are higher today, despite no specific news. Broader market sentiment is cautious following ADP's disappointing employment report.

3 aug 2026, 20:06 UTC

AtriCure Inc. shares are higher during Monday's session, regaining ground after an earlier pullback. Broader market trends support positive investor sentiment.

31 jul 2026, 20:03 UTC

News

AtriCure shares are lower amid significant insider selling, including a $233,280 sale by Chief Scientific Officer Vinayak Doraiswamy and options exercised by Board Member Sven Wehrwein.

30 jul 2026, 18:56 UTC

AtriCure Inc's shares are lower today, impacted by declines in the Health Care Equipment sub-sector. No specific company news was identified for the movement.

29 jul 2026, 20:03 UTC

News

AtriCure Inc shares reached a 52-week high of $43.18 following better-than-expected quarterly earnings, despite a pullback earlier in the session.

28 jul 2026, 19:21 UTC

AtriCure Inc's shares are higher today amid stronger gains in U.S. and European indices, with no specific company news identified for the movement.

27 jul 2026, 20:02 UTC

News

AtriCure Inc shares are higher as the company prepares for two investor conferences and highlights CEO Michael Carrel's leadership appointment.

Peer Vergelijking

Prijswijziging

AtriCure Inc Prognose

Koersdoel

By TipRanks

-5.34% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 55 USD  -5.34%

Hoogste 65 USD

Laagste 36 USD

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor AtriCure Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

8 ratings

6

Buy

2

Hold

0

Sell

Sentiment

By Acuity

56 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over AtriCure Inc

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.